| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $346K | — | — |
| Cost of Revenue | $244K | — | — |
| Gross Profit | $102K | — | — |
| R&D Expense | $1.0M | — | +16.3% |
| SG&A Expense | $14.7M | — | +1220.5% |
| Operating Income | -$15.6M | — | -681.8% |
| Pre-tax Income | -$17.9M | — | +2.9% |
| Net Income | -$17.9M | — | +2.9% |
| EPS (Basic) | -$0.77 | — | -755.6% |
| EPS (Diluted) | -$0.77 | — | -755.6% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $287K | +0.0% | — |
| Inventory | $1.3M | -7.9% | — |
| Current Assets | $5.0M | +142.9% | — |
| Total Assets | $5.1M | +137.0% | — |
| Current Liabilities | $37.8M | -76.0% | — |
| Long-term Debt | $17.7M | — |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | — | -59.2% |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | -$7K | — | — |
| Financing Cash Flow | $2.9M | — | +184.1% |
| Free Cash Flow | -$2.2M | — | — |
| Total Liabilities | $55.6M | -64.8% | — |
| Stockholders' Equity | -$50.5M | +72.6% | +71.7% |